2nd Quarter - Amendment

KNIGHT CAPITOL CONSULTANTS for PERSPECTUM

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Food and Drug Administration regulation of medical devices, including Emergency Use Authorizations for critical products during the COVID-19 crisis.

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Medicare/Medicaid MMM

Reimbursement of new technologies in Medicare, including the Medicare Coverage of Innovative Technology Program.

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff to Senator Orrin G. Hatch

Contacted: Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues associated with diagnosing and treating the effects of COVID-19 appropriately (no specific legislation). Commission to study COVID-19 (draft Menendez proposal, no bill number yet)

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff to Senator Orrin G. Hatch

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

Funding for research and clinical trials related to long term studies of COVID-19 at the National Institutes of Health provided in the Consolidated Appropriations Act of 2021 (PL 116-260).

Foreign entity interest: Perspectum, a leading diagnostic company focused on health solutions that can be achieved at scale through a combination of advanced physics and AI, is headquartered in the United Kingdom.

LobbyistCovered position, as disclosed
PATRICIA KNIGHT Chief of Staff, Senator Orrin G. Hatch

Contacted: Natl Institutes of Health (NIH); SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.